5/5
This work could help improve how existing GLP-1 medicines are used and guide new treatments for inflammatory diseases like arthritis and inflammatory bowel disease. 🙌
@sinaihealth.bsky.social
@sinaihealth.bsky.social5/5
This work could help improve how existing GLP-1 medicines are used and guide new treatments for inflammatory diseases like arthritis and inflammatory bowel disease. 🙌
@vogewekwannalawm.bsky.socialTirz vs Reta - what the trials show:
Tirz: dual agonist, proven, less supply issues
Reta: triple agonist, early data shows +24% fat mass loss vs +14% lean
My research notes: link in profile.
#Retatrutide #Tirzepatide #Peptides #GLP1Research #SleepApnea #Biohacking
